Page last updated: 2024-08-24

lamivudine and Autoimmune Diseases

lamivudine has been researched along with Autoimmune Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, CX; Hua, BL; Jin, HZ; Li, L; Liu, YH; Yan, TM; Zuo, YG1
Mason, A; Neuberger, J; Xu, L1
Asaka, M; Imamura, M; Kanamori, H; Masauzi, N; Mori, A; Tanaka, J; Tsutsumi, Y1
Gilquin, J; Jubault, V; Kazatchkine, MD; Sert, C; Viard, JP1

Reviews

2 review(s) available for lamivudine and Autoimmune Diseases

ArticleYear
Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review.
    The Journal of dermatology, 2017, Volume: 44, Issue:1

    Topics: Adult; Autoantibodies; Autoimmune Diseases; Biopsy; China; Collagen Type VII; Cyclosporine; Epidermolysis Bullosa Acquisita; Esophageal Diseases; Factor VIII; Gastrointestinal Hemorrhage; Glucocorticoids; Hematemesis; Hemophilia A; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Prednisone; Reverse Transcriptase Inhibitors; Skin

2017
Reactivation of hepatitis B virus with rituximab.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibodies, Viral; Antineoplastic Agents; Antiviral Agents; Autoimmune Diseases; Hepatitis B; Hepatitis B virus; Humans; Kinetics; Lamivudine; Lymphoma, Non-Hodgkin; Rituximab

2005

Other Studies

2 other study(ies) available for lamivudine and Autoimmune Diseases

ArticleYear
Proof of principal studies to assess the role of the human betaretrovirus in patients with primary biliary cirrhosis.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:12

    Topics: Autoimmune Diseases; Drug Combinations; Humans; Lamivudine; Liver Cirrhosis, Biliary; Retroviridae Infections; Zidovudine

2004
Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy.
    Lancet (London, England), 1998, Dec-12, Volume: 352, Issue:9144

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Female; Graves Disease; Humans; Immunity; Indinavir; Lamivudine; Male; Ritonavir; Stavudine

1998